SAROJA — Saroja Pharma Industries India Balance Sheet
0.000.00%
- IN₹171.67m
- IN₹273.56m
- IN₹501.93m
- 16
- 67
- 20
- 23
Annual balance sheet for Saroja Pharma Industries India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.753 | 0.041 | 2.65 | 3.64 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 43.7 | 72.7 | 142 | 112 |
Total Inventory | ||||
Total Other Current Assets | ||||
Total Current Assets | 47.6 | 81 | 151 | 161 |
Net Property, Plant And Equipment | 0.509 | 0.831 | 3.42 | 40 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 48.2 | 82.2 | 155 | 213 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 46.1 | 58.7 | 97.9 | 134 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 46.1 | 72.9 | 115 | 163 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 2.05 | 9.36 | 40.3 | 50.9 |
Total Liabilities & Shareholders' Equity | 48.2 | 82.2 | 155 | 213 |
Total Common Shares Outstanding |